Cross CRO-17-132
Laufzeit: 01.01.2019 - 31.12.2019
Kurzfassung
A Phase II, multicentre, randomised, placebo-controlled, doublemasked
trial of RP101 ophthalmic formulation versus vehicle in
post-menopausal women with moderate to severe dry eye
syndrome
